Manabu Muto

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 343 publications

Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.

Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 18, 2026

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Journal: Cancer science

Published: April 07, 2026

Nationwide quality indicator survey on the current practice of esophageal cancer management in Japan: report from the guideline committee for the 6th edition of the Japanese Esophageal Cancer Practice Guidelines.

Nationwide quality indicator survey on the current practice of esophageal cancer management in Japan: report from the guideline committee for the 6th edition of the Japanese Esophageal Cancer Practice Guidelines.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: February 13, 2026

Two cases of durvalumab-induced Evans syndrome in biliary tract cancer.

Two cases of durvalumab-induced Evans syndrome in biliary tract cancer.

Journal: Clinical journal of gastroenterology

Published: January 31, 2026

Community standard practices in the endoscopic treatment of esophageal squamous cell carcinoma: a nationwide survey in Japan.

Community standard practices in the endoscopic treatment of esophageal squamous cell carcinoma: a nationwide survey in Japan.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: January 06, 2026

A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).

A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: January 04, 2026

Phase II trial on nivolumab plus hypofractionated radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial.

Phase II trial on nivolumab plus hypofractionated radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial.

Journal: Immuno-oncology technology

Published: January 01, 2026

HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.

HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.

Journal: Anticancer research

Published: December 28, 2025

Japanese prospective registry study of particle therapy for esophageal cancer including comparison with clinical trials in Japan.

Japanese prospective registry study of particle therapy for esophageal cancer including comparison with clinical trials in Japan.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: November 25, 2025

Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial).

Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial).

Journal: Journal of gastroenterology

Published: November 25, 2025

A case of ER-positive, HER2-negative metastatic breast cancer with high tumor mutation burden achieving complete response to pembrolizumab monotherapy.

A case of ER-positive, HER2-negative metastatic breast cancer with high tumor mutation burden achieving complete response to pembrolizumab monotherapy.

Journal: International cancer conference journal

Published: November 18, 2025

Novel GPRC5B::PRKCA gene fusion in an unclassifiable low-grade glioneuronal tumor.

Novel GPRC5B::PRKCA gene fusion in an unclassifiable low-grade glioneuronal tumor.

Journal: Neuro-oncology advances

Published: November 11, 2025

Showing 1-12 of 343

Last Updated: 09/26/2026